Structure-Based Optimization of the Third Generation Type II Macrocycle TRK Inhibitors with Improved Activity Against Solvent-Front, Xdfg, and Gatekeeper Mutations.
Journal of Medicinal Chemistry（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要